Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-07-17
2007-07-17
Chan, Christina (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007240, C536S023500
Reexamination Certificate
active
10308279
ABSTRACT:
The present invention is directed to polynucleotides encoding polypeptides associated with the development of rheumatoid arthritis and homologs thereof. The invention further relates to diagnostic and therapeutic methods for utilizing these polynucleotides and polypeptides in the diagnosis, treatment, and/or prevention of rheumatoid arthritis and related disease states. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, and compounds identified thereby.
REFERENCES:
patent: 5876923 (1999-03-01), Leopardi et al.
Fridkis-Hareli et al, Human Immunology 61: 640-650, Jul. 2000.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 491-495.
Skolnick et al., From genes to protein structure and function: novel applications of computational approaches in the genomic era, Jan. 2000, Trends in Biotech. 18(1): 34-39.
Singal et al, Ann Rheum Dis 49(3): 143-6, Mar. 1990.
Tsukamoto et al, Immunogenetics 25(5): 343-346, 1987.
Bathon, J.M. et al., “A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis”, The New England Journal of Medicine, vol. 343, No. 22, pp. 1586-1593 (2000).
Bresnihan, B., “The Prospect of Treating Rheumatoid Arthritis with Recombinant Human Interleukin-1 Receptor Antagonist”, BioDrugs, vol. 15, No. 2, pp. 87-97 (2001).
Heller, R.A. et al., “Discovery and analysis of inflammatory disease-related genes using cDNA microarrays”, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 2150-2155 (1997).
Jiang, Y. et al., “A Multicenter, Double-Blind, Dose-Ranging, Randomized, Placebo-Controlled Study of Recombinant Human Interleukin-1 Receptor Antagonist in Patients with Rheumatoid Arthritis”, Arthritis & Rheumatism, vol. 43, No. 5, pp. 1001-1009 (2000).
Jootsen, L.A.B. et al., “IL-1αβ Blockade Prevents Cartilage and Bone Destruction in Murine Type II Collagen-Induced Arthritis, Whereas TNF-α Blockade Only Ameliorates Joint Inflammation”, The Journal of Immunology, vol. 163, pp. 5049-5055 (1999).
Jüsten, H.-P. et al., “Differential Gene Expression in Synovium of Rheumatoid Arthritis and Osteoarthritis”, Molecular Cell Biology Research Communications, vol. 3, pp. 165-172 (2000).
Lipsky, P.E. et al., “Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis”, The New England Journal of Medicine, vol. 343, No. 22, pp. 1594-1602 (2000).
Mizel, S.B. et al., “Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1)”, Proc. Natl. Acad. Sci. USA, vol. 78, No. 4, pp. 2474-2477 (1981).
Niki, Y. et al., “Macrophage- and neutrophil-dominant arthritis in human IL-1α transgenic mice”, The Journal of Clinical Investigation, vol. 107, No. 9, pp. 1127-1135 (2001).
Richard-Miceli, C. et al., “Tumour Necrosis Factor-α Blockers in Rheumatoid Arthritis—Review of the Clinical Experience”, BioDrugs, vol. 15, No. 4, pp. 251-259 (2001).
Seki, T. et al., “Use of a Differential Subtraction Method to Identify Genes that Characterize the Phenotype of Cultured Rheumatoid Arthritis Synoviocytes”, Arthritis & Rheumatism, vol. 41, No. 8, pp. 1356-1364 (1998).
Stuhlmüller, B. et al., “Identification of Known and Novel Genes in Activated Monocytes from Patients with Rheumatoid Arthritis”, Arthritis & Rheumatism, vol. 43, No. 4, pp. 775-790 (2000).
Zanelli, E. et al., “HLA Class II Association with Rheumatoid Arthritis”, Human Immunology, vol. 61, pp. 1254-1261 (2000).
Youssef et al., J. Rheumatol., 26:2523-2528 (1999).
Ng et al., Cancer Research 60:6581-6584 (2000).
Beyeler et al., J. Rheumatol. 27:15-19 (2000).
Yokota et al., J. Rheumatology 28:1952-1959 (2001).
Zhang et al., Nature 383:168-172 (1996).
Crystal, J. of Clinical Investigation 85:1343-1352 (1990).
Cheng et al., Molecular and Cellular Biology 4717-4725 (1991).
Marok et al., Arthritis & Rheumatism 39:583-591 (1996).
Weyand et al.. J. of Clinical Investigation 89:2033-2039 (1992).
Baeuerle et al., Science 242:540-546 (1988).
Bradley et al., J. of Rheumatology 21:1192-1196 (1994).
McInnes et al., Nature Medicine 2:175-182 (1996).
Plaksin et al., J. Exp. Med. 177:1651-1662 (1993).
Nepom, Adv. Immunol. 68:315-332 (1998).
Tetlow et al., British J of Rheumatology 37:64-70 (1998).
Hessian et al., J of Leukocyte Biology 53:197-204 (1993).
Cheng et al., J of Biological Chemistry 258:7746-7750 (1983).
Guenzi et al., EMBO Journal 20:5568-5577 (2001).
Fujihara et al., J of Immunology 165:1004-1012 (2000).
Scheinman et al., Molecular and Cellular Biology 15:943-953 (1995).
Miagkov et al., Proc. Natl. Acad. Sci USA 95:13859-13864 (1998).
McKie et al., Science 291:1755-1759 (2001).
Marquet et al., Mammalian Genome 11:755-762 (2000).
Duchateau et al., J of Biological Chemistry 272:25576-25582 (1997).
Ahn et al., FEBS Letters 366:37-42 (1995).
DaSilva et al., Proc. Natl. Acad. Sci. USA 94:7493-7498 (1997).
Zeng et al., Molecular Biology of the Cell 9:2423-2437 (1998).
Bakker et al., Immunity 13:345-353 (2000).
Paloneva et al., Nature Genetics 25:357-361(2000).
Anderson et al., J of Biological Chemistry 270:29862-29869 (1995).
Aringer et al., Rheumatology 40:876-881 (2001).
Thurkow et al., J of Pathology 181:444-450 (1997).
Torsteinsdottir et al., Clin. Exp. Immunol. 115:554-560 (1999).
Kerkhoff et al., Biochimica et Biophysica Acta 1448:200-211 (1998).
Frosch et al., Arthritis & Rheumatism 43:628-637 (2000).
Cunnane et al., Rheumatology 38:34-42 (1999).
Kerlan-Candon et al., Arthritis & Rheumatism 44:1281-1292 (2001).
Yu et al., J of Biological Chemistry 273:21380-21385 (1998).
Gutierrez et al., J of Cell Biology 139:895-905 (1997).
Schindler et al., Proc. Natl. Acad. Sci. USA 89:7836-7839 (1992).
Ashcroft et al., Nature Cell Biology 1:260-266 (1999).
Knoell et al., Am. J. Respir. Crit. Care Med. 157:246-255(1998).
Dabbagh et al., J of Cellular Physiology 186:73-81 (2001).
Stuhlmuller et al., Arthritis & Rheumatism 43:775-790 (2000).
Zhang et al., J of Immunology 166:6-10 (2001).
Cheema et al., Arthritis & Rheumatism 44:1313-1319 (2001).
Wang et al., Nature Immunology 2:632-637 (2001).
Salmon et al., Arthritis & Rheumatism 44:739-750 (2001).
Yuan et al., Cancer Research 58:2196-2199 (1998).
Peterson et al., Science 293:2263-2265 (2001).
Ruchatz et al., J of Immunology 160:5654-5660 (1998).
Kleinau et al., J. Exp. Med. 191:1611-1616 (2000).
Bowen Michael
Carman Julie
Lu Pin
Nadler Steven G.
Neubauer Michael G.
Bristol--Myers Squibb Company
Chan Christina
Parlet Nickki L.
LandOfFree
Polynucleotides and polypeptides associated with the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotides and polypeptides associated with the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides and polypeptides associated with the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3725071